会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Solvent system enhancing the solubility of pharmaceuticals for
encapsulation
    • 溶剂体系提高药物的包封溶解度
    • US5360615A
    • 1994-11-01
    • US890285
    • 1992-05-26
    • Man S. YuFoo S. HomSibaprasanna ChakrabartiChong-Heng HuangMahendra Patel
    • Man S. YuFoo S. HomSibaprasanna ChakrabartiChong-Heng HuangMahendra Patel
    • A61K9/08A61K9/00A61K9/20A61K9/48A61K9/66A61K45/00A61K47/00A61K47/04A61K47/32A61K47/34
    • A61K9/2009A61K9/2031A61K9/485A61K9/4858A61K9/4866
    • This invention relates to a solvent system for enhancing the solubility of an acidic, basic, or amphoteric pharmaceutical agent to produce a highly concentrated solution suitable for softgel filling or two piece encapsulation. The solvent system comprises polyethylene glycol containing 0.2-1.0 mole equivalents of an ionizing agent per mole equivalent pharmaceutical agent and 1-20% water. Glycerin or polyvinylpyrrolidone may be added to further enhance the solubility of certain drugs. The disclosed solvent system is capable of enhancing solubilities of pharmaceutical agents 40-400%.The ionizing agent functions by causing partial ionization (neutralization) of the free pharmaceutical agent. When the pharmaceutical agent is acidic, the ionizing agent is preferably a hydroxide ion species, whereas when the pharmaceutical agent is basic, the ionizing agent is preferably a hydrogen ion species. For amphoteric pharmaceutical agents, either hydroxide ion or hydrogen ion sources may be utilized to effect partial ionization.The disclosed solvent system is useful because it not only provides for the enhancement or improvement of bioavailability of acidic, basic and amphoteric pharmaceutical agents by delivering them already in solution, but it also provides for a highly concentrated solution capable of encapsulation in a small enough vessel to permit easy swallowing.The highly concentrated solid solutions of the present invention are also useful for conversion into tablets and as veterinary spot and pour on preparations.
    • 本发明涉及一种用于增强酸性,碱性或两性药剂在产生适于软胶囊填充或两片封装的高度浓缩溶液中的溶解度的溶剂体系。 溶剂系统包含每摩尔当量药剂和1-20%水含有0.2-1.0摩尔当量离子化剂的聚乙二醇。 可以加入甘油或聚乙烯吡咯烷酮以进一步提高某些药物的溶解度。 所公开的溶剂系统能够提高40-400%的药剂的溶解度。 电离剂通过引起游离药剂的部分电离(中和)起作用。 当药剂为酸性时,电离剂优选为氢氧根离子,而当药剂为碱性时,电离剂优选为氢离子。 对于两性药剂,可以使用氢氧根离子或氢离子源来实现部分电离。 所公开的溶剂系统是有用的,因为它不仅通过将其输送到溶液中来提供酸性,碱性和两性药物的生物利用度的增强或改善,而且还提供能够在足够小的容器中包封的高度浓缩的溶液 容易吞咽。 本发明的高度浓缩的固体溶液也可用于转化成片剂和兽药斑点并倒入制剂上。
    • 2. 发明授权
    • Solvent system enhancing the solubility of pharmaceuticals for
encapsulation
    • 溶剂系统提高药物的溶解度
    • US5071643A
    • 1991-12-10
    • US104911
    • 1987-10-09
    • Man S. YuFoo S. HomSibaprasanna ChakrabartiChong-Heng HuangMahendra Patel
    • Man S. YuFoo S. HomSibaprasanna ChakrabartiChong-Heng HuangMahendra Patel
    • A61K9/08A61K9/00A61K9/20A61K9/48A61K9/66A61K45/00A61K47/00A61K47/04A61K47/32A61K47/34
    • A61K9/2009A61K9/2031A61K9/485A61K9/4858A61K9/4866
    • This invention relates to a solvent system for enhancing the solubility of an acidic, basic, or amphoteric pharmaceutical agent to produce a highly concentrated solution suitable for softgel filling or two piece encapsulation. The solvent system comprises polyethylene glycol containing 0.2-1.0 mole equivalents of an ionizing agent per mole equivalent pharmaceutical agent and 1-20% water. Glycerin or polyvinylpyrrolidone may be added to further enhance the solubility of certain drugs. The disclosed solvent system is capable of enhancing solubilities of pharmaceutical agents 40-400%.The ionizing agent functions by causing partial ionization (neutralization) of the free pharmaceutical agent. When the pharmaceutical agent is acidic, the ionizing agent is preferably a hydroxide ion species, whereas when the pharmaceutical agent is basic, the ionizing agent is preferably a hydrogen ion species. For amphoteric pharmaceutical agents, either hydroxide ion or hydrogen ion sources may be utilized to effect partial ionization.The disclosed solvent system is useful because it not only provides for the enhancement or improvement of bioavailability of acidic, basic and amphoteric pharmaceutical agents by delivering them already in solution, but it also provides for a highly concentrated solution capable of encapsulation in a small enough vessel to permit easy swallowing.The highly concentrated solid solutions of the present invention are also useful for conversion into tablets and as veterinary spot and pour on preparations.
    • 本发明涉及一种用于增强酸性,碱性或两性药剂在产生适于软胶囊填充或两片封装的高度浓缩溶液中的溶解度的溶剂体系。 溶剂系统包含每摩尔当量药剂和1-20%水含有0.2-1.0摩尔当量离子化剂的聚乙二醇。 可以加入甘油或聚乙烯吡咯烷酮以进一步提高某些药物的溶解度。 所公开的溶剂系统能够提高40-400%的药剂的溶解度。 电离剂通过引起游离药剂的部分电离(中和)起作用。 当药剂为酸性时,电离剂优选为氢氧根离子,而当药剂为碱性时,电离剂优选为氢离子。 对于两性药剂,可以使用氢氧根离子或氢离子源来实现部分电离。 所公开的溶剂系统是有用的,因为它不仅通过将其输送到溶液中来提供酸性,碱性和两性药物的生物利用度的增强或改善,而且还提供能够在足够小的容器中包封的高度浓缩的溶液 容易吞咽。 本发明的高度浓缩的固体溶液也可用于转化成片剂和兽药斑点并倒入制剂上。
    • 4. 发明授权
    • Sustained release method and product
    • 持续释放方法和产品
    • US4800083A
    • 1989-01-24
    • US921069
    • 1986-10-20
    • Foo S. HomWilliam R. Ebert
    • Foo S. HomWilliam R. Ebert
    • A61K9/48A61K9/52A61K9/68
    • A61K9/4858A61K9/4866
    • A capsule product and method for gradually releasing a medicament for absorption to a body of a warm blooded animal through the gastrointestinal system. The capsule has a fill material which includes a masticatory substance and a medicament that is dispersed throughout the gum. The medicament is of a type that is effectively and desirably released for absorption by the body through the gastrointestinal tract over an extended period of time. The masticatory substance forms a supporting cohesive matrix for the medicament. The gelatin shell, usually formed from gelatin, water, and a plasticizer, formed around the fill material into a capsule of a size and shape to be readily swallowable. Upon swallowing, the gelatin shell is rapidly dissolved in the gastrointestinal juices, while the fill material is substantially insoluble in the gastrointestinal juices. The matrix having the medicament dispersed throughout is subjected to substantially continuous random motion while contained within the gastrointestinal juices, while at body temperatures, and while under the influence of peristaltic movement for substantially varying the exposed surface area of the fill. As the surface area of the fill material is being changed, the medicament is gradually released from the exposed surface area for an extended period of time for ultimate absorption of the drug by the body.
    • 一种胶囊产品和方法,用于通过胃肠系统逐渐释放用于吸收温血动物身体的药物。 胶囊具有填充材料,其包括咀嚼物质和分散在整个牙龈中的药物。 药物是一种有效和期望地释放的类型,其被身体通过胃肠道在延长的时间段内吸收。 咀嚼物形成用于药物的支持性内聚基质。 通常由明胶,水和增塑剂形成的明胶壳体,其形成在填充材料周围,成为容易吞咽的尺寸和形状的胶囊。 吞咽后,明胶壳迅速溶解在胃肠液中,而填充物质基本上不溶于胃肠液。 具有分散在其中的药物的基质在包含在胃肠液中的同时在体温下并且在蠕动运动的影响下受到基本上连续的随机运动,用于基本上改变填充物的暴露的表面积。 随着填充材料的表面积改变,药物从暴露的表面区域逐渐释放一段较长的时间,以最终吸收身体的药物。